Editiorial: Relevant Research: Will this Confirm or Change my Practice?

How Relevant Is This to My Practice?

234 1Department of Gastroenterology and Hepatology, Changi General Hospital, 2Central 24-HR Clinic Group, Singapore Correspondence: Adj A/Prof Tiing Leong Ang, Chief and Senior Consultant, Department of Gastroenterology and Hepatology, Changi General Hospital, 2 Simei Street 3, Singapore 529889. [email protected] HOW RELEVANT IS THIS TO MY PRACTICE? Helicobacter pylori (H. pylori) is a...

Will this trial change my practice? ABSORB II trial (a bioresorbable vascular scaffold versus drug-eluting stent in coronary disease).

1.The Heart Hospital, University College London Hospitals UCLH, London, United Kingdom; 2. Deutsches Herzzentrum München, Technische Universität München and DZHK (German Centre for Cardiovascular Research), partner site Munich Heart Alliance, Munich, Germany; 3. Thoraxcenter, Erasmus Medical Center, Rotterdam, The Netherlands; 4. Department of Cardiology, Bern University Hospital, Bern, Switzer...

This number will be updated

How will NHI affect my practice? Workshop seeks answers.

COPD heterogeneity: what this will mean in practice.

COPD is a complex collection of conditions. All share the feature of limited expiratory air flow. It is a "disease" in the same sense as is "chronic renal failure." Like most other chronic organ failure "diseases," COPD has disparate causes, and patients are heterogeneous in their prognosis and response to treatment. Unlike many other diseases, the heterogeneity of COPD is just beginning to be ...